ArticleOncology letters2016

Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients.

Rania Bakry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.